Goda utsikter för Astra – FDA varnar Novo

from Börsfrukost · host EFN Ekonomikanalen

Ännu en rapportfylld morgon där bland annat läkemedelsjätten Astra Zeneca rapporterat och prickade förväntningarna.Danska Novo Nordisk såg ett lyft efter att amerikanska FDA stoppat konkurrenten Hims & Hers kopior. Läkemedelsförvaltaren Amennai Beyeen gästar Börsfrukost som leds av Kelly Connelin.

Episode metadata supplied by the publisher feed · Published Feb 10, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Goda utsikter för Astra – FDA varnar Novo

0:00 12:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Börsfrukost?

This episode is 12 minutes long.

When was this Börsfrukost episode published?

This episode was published on February 10, 2026.

Can I download this Börsfrukost episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!